Our Services

Clinical Trials

Protocol

Type of Trial

 Sponsorship*

Reduced Intensity Conditioning Hematopoietic Cell Transplantation for Pediatric Patients with Hematologic Malignancies at High Risk for Transplant Related Mortality with Standard Transplantation; A Multi-center Trial for the Pediatric Blood and Marrow Transplant Consortium (PBMTC) Treatment  PBMTC
Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia  Treatment  Limited Institution Pilot
ANBL0032, Phase III Randomized Study of Chimeric Anti-GD2 in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue  Treatment  COG
Initial Systemic Treatment of Acute GVHD: A Phase II Randomized Trial Evaluation Etancercept, Mycophenolate Mofetil (MMF), Denieukin Difitox (Ontak) and Pentostatin in Addition to Corticosteriods  Treatment  BMT CTN
National Marrow Donor Program (NMDP) Recipient Consent for Participation in Research Database and/or Research Sample Respository  Biology  NMDP
GVH0112, Cytokine Gene Polymorphisms in Pediatric Patients Receiving Tacrolimus or Cyclosporin for Graft-versus-Host Disease Prophylaxis  Biology  PBMTC
PBMTC051: Soluble Tumor Necrosis Factor Receptor Embrel (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome following Allogeneic Stem Cell Transplantation  Treatment  COG
 
For more information about trial participation, please call 412-692-6740.
 

*Sponsorships

COG = Children’s Oncology Group
NMDP = National Marrow Donor Program
PBMTC = Pediatric Blood & Marrow Transplant Consortium
BMT CTN = Blood and Marrow Transplant Clinical Trials Network

Last Update
October 12, 2012
  • Increase/Decrease Text Size
  • Print This Page
Last Update
October 12, 2012
top